Compare BWLP & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWLP | LMAT |
|---|---|---|
| Founded | 1935 | 1983 |
| Country | Singapore | United States |
| Employees | 1444 | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.2B |
| IPO Year | N/A | 2006 |
| Metric | BWLP | LMAT |
|---|---|---|
| Price | $21.44 | $91.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $105.80 |
| AVG Volume (30 Days) | ★ 533.4K | 246.0K |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.51% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ $15.61 | $135.79 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $11.59 | $79.01 |
| 52 Week High | $22.92 | $118.01 |
| Indicator | BWLP | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 35.10 |
| Support Level | $19.33 | $89.81 |
| Resistance Level | $22.92 | $92.25 |
| Average True Range (ATR) | 0.61 | 2.86 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 73.20 | 16.39 |
BW LPG Ltd is an owner and operator of very large gas carriers. It operates in two segments: the Shipping segment, which includes LPG shipping and the Product Services segment, which includes the core shipping business. The Product Services segment derives the majority of the revenue.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.